Evidence map›Paper›PMID 33214662›Full record

ArticleScientific reports2020

A prediction model for outcome in patients with HBV-ACLF based on predisposition, injury, response and organ failure.

Fangfang Liu, Zhengsheng Zou, Lijun Shen, Weiwei Wu, Jiajun Luo, Seth Lankford, Yongli Yang, Huang Huang, Shaoli You, Bing Zhu and 4 more

Abstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Fangfang LiuLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Zhengsheng ZouLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Lijun ShenMedical School of Chinese PLA, Beijing, China.
Weiwei WuDepartment of Epidemiology, School of Public Health, Shanxi Medical University, Taiyuan, Shanxi, China.
Jiajun LuoDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
Seth LankfordDuke University, Durham, NC, USA.
Yongli YangDepartment of Epidemiology and Health Statistics, College of Public Health, Zhengzhou University, Zhengzhou, Henan, China.
Huang HuangDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA.
Shaoli YouLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Bing ZhuLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Jin LiLiver Disease Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.
Jinsong MuCritical Care Department, Fifth Medical Center of Chinese PLA General Hospital, Beijing, China. jinsongmu302@163.com.
Yawei ZhangDepartment of Environmental Health Sciences, Yale School of Public Health, Yale University, New Haven, CT, USA. yawei.zhang@yale.edu.
Shaojie XinMedical School of Chinese PLA, Beijing, China. xinshaojie302@163.com.

Funding

Yale Clinical and Translational Science Award (U Component)UL1TR001863 · NCATS · YALE UNIVERSITY · PI John H. Krystal, LUCILA OHNO-MACHADO · 2016 to 2026
$102.9M
NCATS NIH HHS UL1 TR001863
6 · The paper itself

Abstract

We aimed to develop a prediction model based on the PIRO concept (Predisposition, Injury, Response and Organ failure) for patients with Hepatitis B Virus (HBV) related acute-on-chronic liver failure (ACLF). 774 patients with HBV related ACLF defined in the CANONIC study were analyzed according to PIRO components. Variables associated with mortality were selected into the prediction model. Based on the regression coefficients, a score for each PIRO component was developed, and a classification and regression tree was used to stratify patients into different nodes. The prediction model was then validated using an independent cohort (n = 155). Factors significantly associated with 90-day mortality were: P: age, gender and ACLF type; I: drug, infection, surgery, and variceal bleeding; R: systemic inflammatory response syndrome (SIRS), spontaneous bacteria peritonitis (SBP), and pneumonia; and O: the CLIF consortium organ failure score (CLIF-C OFs). The areas under the receiver operating characteristics curve (95% confidence interval) for the combined PIRO model for 90-day mortality were 0.77 (0.73-0.80). Based on the scores for each of the PIRO components and the cut-offs estimated from the classification and regression tree, patients were stratified into different nodes with different estimated death probability. Based on the PIRO concept, a new prediction model was developed for patients with HBV related ACLF, allowing stratification into different clusters using the different scores obtained in each PIRO component. The proposed model will likely help to stratify patients at different risk, defining individual management plans, assessing criteria for specific therapies, and predicting outcomes.

Indexed as

Acute-On-Chronic Liver FailureAdultCohort StudiesDisease SusceptibilityFemaleGastrointestinal HemorrhageHepatitis BHumansMaleMiddle AgedModels, StatisticalMultivariate AnalysisOrgan Dysfunction ScoresPrognosisReproducibility of ResultsROC Curve

Identifiers

PMID33214662
PMCPMC7677318

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.